Role of lamivudine in the posttransplant prophylaxis of chronic hepatitis B virus and hepatitis delta virus coinfection

Transplantation

Volumn 83, Issue 10, 2007, Pages 1341-1344

  Caccamo, Lucio ^a   Agnelli, Francesca ^a   Reggiani, Paolo ^a   Maggi, Umberto ^a   Donato, M Francesca ^a   Gatti, Stefano ^a   Paone, Giovanni ^a   Melada, Ernesto ^a   Rossi, Giorgio ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Hepatitis B virus; Hepatitis delta virus; Lamivudine; Liver transplantation; Outcome

Indexed keywords

CYCLOSPORIN; HEPATITIS B ANTIBODY; LAMIVUDINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; STEROID; TACROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMAN; IMMUNOPROPHYLAXIS; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SUPERINFECTION; VIRUS CARRIER;

ADULT; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS D; HUMANS; IMMUNOGLOBULINS; LAMIVUDINE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REOPERATION; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE INHIBITORS; SURVIVAL ANALYSIS;

EID: 34249062310     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000264001.69308.be     Document Type: Article

References (19)

1. Ben-Ari Z, Mor E, Tur-Kaspa R. Experience with lamivudine therapy for hepatitis B virus infection before and after liver transplantation, and review of the literature. J Int Med 2003; 253: 544.
2. Samuel D, Muller R, Alexander G, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Eng J Med 1993; 329: 1842.
3. Roche B, Samuel D. Evolving strategies to prevent HBV recurrence. Liver Transpl 2004; 10: S74.
4. Starkel P, Ciccarelli O, Lerut J, et al. Limited lamivudine and long-term hepatitis B immunoglobulin immunoprophylaxis for prevention of hepatitis B recurrence after liver transplantation. Transplantation 2002; 74: 408.
5. Naoumov NV, Ross Lopes A, Burra P, et al. Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation. J Hepatol 2001; 34: 888.
6. Niro GA, Rosina F Rizzetto M. Treatment of hepatitis D. J Viral Hep 2005; 12: 2.
7. Samuel D, Zignego AL, Reynes M, et al. Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis. Hepatology 1995; 21: 333.
8. Grazi GL, Mazziotti A, Sama C, et al. Liver transplantation in HBsAg-positive HBV-DNA-negative cirrhotics: Immunoprophylaxis and long-term outcome. Liver Transpl Surg 1996; 2: 418.
9. Steinmuller T, Seehofer D, Rayes N, et al. Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease. Hepatology 2002; 35: 1528.
10. Lerut JP, Donataccio M, Ciccarelli O, et al. Liver transplantation and HBsAg-positive postnecrotic cirrhosis: Adequate immunoprophylaxis and delta virus co-infection as the significant determinants of longterm prognosis. J Hepatol 1999; 30: 706.
11. Marzano A, Gaia S, Ghisetti V, et al. Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence. Liver Transplant 2005; 11: 402.
12. Niro GA, Ciancio A, Tillmann HL, et al. Lamivudine therapy in chronic delta hepatitis: A multicentre randomized-controlled pilot study. Aliment Pharmacol Ther 2005; 22: 227.
13. Caccamo L, Romeo R, Rossi G, et al. No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutants. Transpl Int 2005; 18: 186.
14. Caccamo L, Rossi G, Reggiani P, et al. Liver transplantation for viral hepatitis-associated cirrhosis. Transplant Proc 1998; 30: 2107.
15. Roche B, Feray C, Gigou M, et al. HBV DNA persistence 10 years after liver transplantation despite successful anti-HBs passive immunoprophylaxis. Hepatology 2003; 38: 86.
16. Rosenau J, Bahr MJ, Tillmann HL, et al. Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection. J Hepatol 2001; 34: 895.
17. Dan YY, Wai CT, Yeoh KG, Lim SG. Prophylactic strategies for hepatitis B patients undergoing liver transplant: A cost-effectiveness analysis. Liver Transpl 2006; 12: 736.
18. Burbach GJ, Bienzle U, Neuhaus R, et al. Intravenous or intramuscular anti-HBs immunoglobulin for the prevention of hepatitis B reinfection after orthotopic liver transplantation. Transplantation 1997; 63: 478.
19. Nath DS, Kalis S, Payne WD, et al. Hepatitis B prophylaxis post-liver transplant without maintenance hepatitis B immunoglobulin therapy. Clin Transplant 2006; 20: 206.